Search…

Yuandong Biotechnology: plans to invest 85.71 million yuan to acquire controlling stake in Shanghai Chaoyang.

23/09/2025

Yuan Dong Biology Announcement: The company intends to invest in Shanghai Chaoyang Pharmaceutical Co., Ltd., with a total investment amount of 85.71 million yuan, all of which will be sourced from its own funds. This transaction constitutes a related party transaction. This transaction does not constitute a major asset restructuring.

Latest

1 m ago

J.P. Morgan's U.S. Treasury client survey shows that short positions have jumped to the highest level since February 3rd.

1 m ago

JPMorgan Chase's US Treasury client survey as of the week ending September 22nd showed that the percentage of short positions increased by 4 percentage points, long positions increased by 3 percentage points, and neutral positions decreased by 7 percentage points. The survey of all clients showed that the percentage of short positions reached the highest level since February 3rd.

1 m ago

The final stage of negotiations on Boeing (BA.US) orders between China and the United States has been entered, with reports indicating that the scale may reach 500 aircraft.

1 m ago

*ST Xingnong: Shareholder Li Weihong plans to reduce his stake in the company by no more than 3%.*

2 m ago

The Hong Kong Monetary Authority provided banks with HK$376 million in liquidity through its discount window.

See all latest